Christopher P. Boone, PhD is an accomplished global executive, strategist, professor, social scientist, and data technologist with a passion for reinventing and transforming healthcare and life sciences companies utilizing enterprise data & analytics capabilities to drive value creation. Chris has a career-long history as a dynamic, innovative, and transformative data & analytics executive, thought leader and a public voice on the power of real-world evidence, health informatics, and enterprise data & analytics, and its ability to radically transform the global health care system into a learning health care system.

Currently, Chris serves as the Vice President, Global Head of Health Economics and Outcomes Research at AbbVie. He is also an adjunct assistant professor of health administration at the New York University’s Robert F. Wagner Graduate School of Public Service, an active board member of several influential organizations, and a co-founder of a few start-up companies. Prior to AbbVie, he served in two different roles at Pfizer: (1) the Vice President and Head of Global Medical Epidemiology and Big Data Analysis, and (2) the Vice President and Global Head of Real-World Data and Analytics.

Chris has been recognized as a inducted member of the Executive Leadership Council (2023), Top 50 Leadership Excellence Award by the National Diversity and Leadership Council (2023, 2021), a Global Top 100 Innovator in Data & Analytics (2020, 2019), an Emerging Pharma Leader by Pharmaceutical Executive (2018), and a Top 40 Under 40 Leaders in Health (2017) by the National Minority Quality Forum.

Chris holds appointments to some of the most influential national committees focused on health data and patient centricity, including the Board of Governors for PCORI, the Board of Directors for Global Medical Response, the Board of Directors for Stewards of Change Institute, the Advisory Board of Mango Sciences, the Advisory Board of TrialBee, the American Heart Association’s Clinical Studies Expert Panel, the Global Liver Institute for Liver Health Equity Advisory Board, and the Strategic Advisory Committee for the Texas Biomedical Institute. 

In the past, Chris has served on other committees over his career, including the Executive Board of Directors for the Patient Advocate Foundation, the Executive Board of Directors for the National Patient Advocate Foundation, the U.S. Department of Health and Human Services (HHS) Federal Health IT Policy Committee, the HHS National Committee on Vital and Health Statistics (NCVHS) Working Group on HHS Data Access and Use, the advisory group for American Society of Clinical Oncologists’ (ASCO) CancerLinQ, the Board of Directors for SHARE for Cures, the Robert Wood Johnson Foundation’s Data Across Sectors for Health (DASH) Initiative, and the Interoperability Committee for the National Quality Forum.   

Chris earned a B.S. in Management Information Systems from the University of Tulsa, a M.S. in Healthcare Administration from the University of Texas at Arlington, a Ph.D. In Public Affairs & Health Policy from the University of Texas at Dallas, and two executive certificates from the Harvard Kennedy School. He is a Fellow of the American College of Health Executives and a Fellow of the Healthcare Information Management & Systems Society.